News

Pharmaceutical Technology on MSN18h
China approves InnoCare Pharma’s BTK inhibitor for lymphoma
China’s NMPA has approved InnoCare Pharma’s orelabrutinib for use as a first-line treatment for CLL and small lymphocytic ...
Pharmabiz20h
China NMPA approves InnoCare Pharma’s orelabrutinib for first-line treatment of patients with CLL/SLL
China NMPA approves InnoCare Pharma’s orelabrutinib for first-line treatment of patients with CLL/SLL: Beijing Monday, April 28, 2025, 12:00 Hrs [IST] InnoCare Pharma, a leading ...
6abc Action News9h
The Philadelphia-created treatment changing prospects for lymphoma
FOX CHASE (WPVI) -- We often connect cancer to one part of the body. Lymphoma, however, can attack almost anywhere. But a ...
St. Louis Post-Dispatch20h
In a first for St. Louis, patient completes new gene therapy to cure sickle cell disease
Cancel anytime. Martin Mwita and his mother Jacinta Mwita, both of Omaha, speak about his journey living with sickle cell disease and receiving treatment from St. Louis Children’s Hospital on ...